trending Market Intelligence /marketintelligence/en/news-insights/trending/dwOebbXKxlEu_6wSx0QoFg2 content esgSubNav
In This List

Catalyst Biosciences chairman stepping down; replacement named

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Catalyst Biosciences chairman stepping down; replacement named

Barry Selick is stepping down as a board member and chairman of Catalyst Biosciences Inc. on Feb. 15, 2018.

Current board member Augustine Lawlor will replace Selick as chairman.

Also, the company appointed Edward Williams as a board member, effective Jan. 1, 2018.

Williams was most recently senior vice president of biopharmaceuticals at Novo Nordisk Inc.